All Stories

  1. Bone mineral density among virologically suppressed Asians older than 50 years old living with and without HIV: A cross-sectional study

    Article • PLOS One, November 2022, PLOS

    Dr Anchalee Avihingsanon

  2. Bone mineral density changes among people living with HIV who have started with TDF-containing regimen: A five-year prospective study

    Article • PLOS One, March 2020, PLOS

    Dr Anchalee Avihingsanon

  3. Efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in Asian participants with human immunodeficiency virus 1 infection: A sub-analysis of phase 3 clinical trials

    Article • HIV Research & Clinical Practice, July 2019, Taylor & Francis

    Dr Anchalee Avihingsanon, Gordon Strachan

  4. Antiretroviral-naïve HIV-infected patients had lower bone formation markers than HIV-uninfected adults

    Article • AIDS Care, May 2019, Taylor & Francis

    Dr Anchalee Avihingsanon, Nittaya Phanuphak, Lalita Wattanachanya

  5. Rationale and clinical utility of the darunavir–cobicistat combination in the treatment of HIV/AIDS

    Article • Drug Design Development and Therapy, October 2015, Dove Medical Press

    Dr Anchalee Avihingsanon, Tanya C Do